While MCA-PSV is commonly used in the Western world for evaluation of fetuses at risk of anemia secondary to any causes, this study demonstrates that CV has a significantly higher performance than that of MCA-PSV in predicting fetal Hb Bart’s disease. The gene discussed is GSTM1; the disease is anemia.